EY How fit is your capital allocation strategy

ey-how-fit-is-your-capital-allocation-strategy

arc beats above · slides in the middle · loops below · scroll → 2 LOOPS

Deck intelligence map

coverage by narrative range · generated from this deck JSON

Narrative range 24 total

Metadata

Components

Metrics

Tools

Frameworks

Beats

Loops

Situation & Context 3 slides 100% 3/3 slides 100% 3/3 slides · 10 hits

— 0/3 slides

66.7% 2/3 slides 33.3% 1/3 slides 100% 3/3 slides 33.3% 1/3 slides Problem & Complication 3 slides 100% 3/3 slides 100% 3/3 slides · 13 hits

— 0/3 slides

66.7% 2/3 slides 33.3% 1/3 slides 100% 3/3 slides 100% 3/3 slides Evidence & Proof 9 slides 100% 9/9 slides 100% 9/9 slides · 38 hits

— 0/9 slides

88.9% 8/9 slides 22.2% 2/9 slides 100% 9/9 slides

— 0/9 slides

Solution & Approach 7 slides 100% 7/7 slides 100% 7/7 slides · 23 hits

— 0/7 slides

71.4% 5/7 slides 28.6% 2/7 slides 100% 7/7 slides 28.6% 2/7 slides Impact & Next Steps 2 slides 100% 2/2 slides 100% 2/2 slides · 9 hits

— 0/2 slides

100% 2/2 slides

— 0/2 slides

Slide inventory

every slide · same image gating as the playbook

The slide uses a metaphor of physical fitness to introduce a business topic.front_matter

Open slide detailBeat · Situation & Context

other

Open slide detailBeat · Situation & Context

The slide uses a dark grey background for the list of pressures and a yellow background for the concluding warning about activism.frame_problem

Open slide detailBeat · Situation & ContextLoop · Cost Of Inaction

establish_context

Open slide detailBeat · Problem & ComplicationLoop · Cost Of Inaction

The chart uses a dual-axis approach to show market cap (bars) and campaign frequency (line).analyze_data

Open slide detailBeat · Problem & ComplicationLoop · Cost Of Inaction

present_framework

Open slide detailBeat · Problem & ComplicationLoop · Cost Of Inaction

transition

Open slide detailBeat · Evidence & Proof

The chart shows year-over-year growth percentages within stacked segments for each year.compare_peers

Open slide detailBeat · Evidence & Proof

Ex-Gilead biotech margins are provided as a footnote.compare_peers

Open slide detailBeat · Evidence & Proof

The chart shows four lines: Top tier, Median, Activist targets, and Bottom tier from 2009 to 2014.compare_peers

Open slide detailBeat · Evidence & Proof

summarize

Open slide detailBeat · Evidence & Proof

summarize

Open slide detailBeat · Evidence & Proof

transition

Open slide detailBeat · Evidence & Proof

The chart uses a mirrored bar chart structure to contrast two different industry segments.compare_options

Open slide detailBeat · Evidence & Proof

The slide features a report cover image titled 'Cash on prescription'.summarize

Open slide detailBeat · Evidence & Proof

transition

Open slide detailBeat · Solution & Approach

The 2015 bar includes a '2015 pipeline (2H)' segment, indicating projected or pending activity.analyze_data

Open slide detailBeat · Solution & Approach

The chart uses a combination of bar (deal value) and line (number of divestitures) to show trends.analyze_data

Open slide detailBeat · Solution & Approach

transition

Open slide detailBeat · Solution & Approach

Includes a quote from Paul Clancy, CFO of Biogen, regarding capital deployment.present_framework

Open slide detailBeat · Solution & Approach

The slide uses a 2x2 grid with bidirectional arrows indicating interdependencies between the four pillars.present_framework